Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...

Pfizer got a reprieve in January when Starboard didn’t nominate its own slate of directors to the company’s board, but the activist could still agitate for changes next year.

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert Bourla, claiming at least $20 billion in value – and possibly as much as $60 ...

The American hedge fund Starboard Value has acquired a stake in Pfizer Inc. worth $1 billion. This is reported in the Starboard Value press release. Starboard Value is committed to accelerating the ...

Jonathan Rockoff is the Health Business editor at The Wall Street Journal, managing a team that reports on pharmaceutical and biotechnology companies, health insurers and hospitals. During the ...

Pfizer is deeply undervalued, and has a high dividend yield, and I see tons of institutions and analysts buying the dip. Read ...

Pfizer Price Performance Shares of Pfizer stock opened at $22.95 on Friday. The company has a quick ratio of 0.73, a current ratio of 1.00 and a debt-to-equity ratio of 0.63. Pfizer has a 52 week ...

Pfizer recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its oncology portfolio through advanced liquid biopsy technology. Simultaneously, the company ...

As Pfizer navigates these challenges, it faces rising competition from agile biotech firms wielding AI, gene editing, and mRNA technologies. By 2030, these innovators could surpass Pfizer’s drug ...

Pfizer Inc. (NYSE:PFE – Get Free Report)’s stock price rose 1.5% during mid-day trading on Thursday following a dividend announcement from the company. The stock traded as high as $22.74 and ...

Guardant and Pfizer will use liquid biopsy tests in global oncology clinical trials, including monitoring ctDNA as a therapy response marker Pfizer gains access to Guardant’s testing ...